The primary outcome is the frequency of patients with at least one sepsis-like event, defined by any association of suspected sepsis symptoms with a level of c-reactive protein (CRP) > 5 mg/L in a negative-culture contest, from the beginning up to 48 h after discontinuation of infusion therapy. The gene discussed is CRP; the disease is Sepsis.